Synthesis and Leishmanicidal Activity of 1-[5-(5-Nitrofuran-2-yl)-1, 3, 4-Thiadiazole-2-yl]-4-BenzoylePiperazines

A series of (5-nitrofuran-2-yl)-1, 3, 4-thiadiazole-2-yl derivatives 6a–6e have been synthesized and screened for in-vitro anti-leishmanial activity against the promastigote form of L. major. The structure of Schiff bases were confirmed by 1H NMR, IR. Screening results indicate that all of the designed and synthesized final compounds (6a-6e) significantly reduced the viability of promastigotes of L. major in comparison toglucantime (IC50 3× 103 μg/mL). Meta and Para substitutions in benzene ring containing compounds were more potent than other derivative and the most potent compounds were 6d, 6e with IC50 value 94 µm and 77.6 µm, respectively. The experimental data proposes that (5-nitrofuran-2-yl)-1, 3, 4-thiadiazole-2-yl derivatives may be further investigated as a candidate drug for treatment of cutaneous leishmaniasis.

[1]  Y. Hamzavi,et al.  Trend of Cutaneous Leishmaniasis in Kermanshah Province, West of Iran from 1990 To 2012 , 2015, Iranian journal of parasitology.

[2]  M. Mohebali Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features , 2013, Iranian journal of parasitology.

[3]  S. Kaur,et al.  Vaccine candidates for leishmaniasis: a review. , 2011, International immunopharmacology.

[4]  A. Shafiee,et al.  Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents. , 2011, European journal of medicinal chemistry.

[5]  R. Uddin,et al.  Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. , 2010, European journal of medicinal chemistry.

[6]  A. Kadi,et al.  Synthesis, antimicrobial and anti-inflammatory activities of novel 5-(1-adamantyl)-1,3,4-thiadiazole derivatives. , 2010, European journal of medicinal chemistry.

[7]  H. Abdel‐Aziz,et al.  Synthesis and antimicrobial evaluation of some 1,3-thiazole, 1,3,4-thiadiazole, 1,2,4-triazole, and 1,2,4-triazolo[3,4-b][1,3,4]-thiadiazine derivatives including a 5-(benzofuran-2-yl)-1-phenylpyrazole moiety , 2009 .

[8]  A. Kariminia,et al.  Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species. , 2009, Experimental parasitology.

[9]  A. Shafiee,et al.  Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines. , 2008, Bioorganic & medicinal chemistry.

[10]  J. Matysiak,et al.  2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazole analogues: Antifungal activity in vitro against Candida species , 2007, Russian Journal of Bioorganic Chemistry.

[11]  L. Kedzierski,et al.  Leishmania vaccines: progress and problems , 2006, Parasitology.

[12]  M. Ouellette,et al.  Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites , 2006, PLoS medicine.

[13]  M. Mirzaei,et al.  Antituberculosis agents. V. Synthesis, evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(5-nitro-2-furyl)-1,3,4-thiadiazole derivatives. , 2002, Farmaco.

[14]  D. Simoni,et al.  3,6-Disubstituted 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles: synthesis, antimicrobial and antiviral activity. II. , 1996, Farmaco.

[15]  H. Ishikawa,et al.  Synthesis and anti-pseudomonal activity of new 2-isocephems with a dihydroxypyridone moiety at C-7 , 1994 .

[16]  P. Desjeux,et al.  Estimation of population at risk of infection and number of cases of Leishmaniasis. , 1992, Parasitology today.

[17]  A. Fuertes,et al.  Coordination behavior of acetazolamide (5-acetamido-1,3,4-thiadiazole-2-sulfonamide): synthesis, crystal structure, and properties of bis(acetazolamidato)tetraamminenickel(II) , 1989 .